FDA Approved: BLEOMYCIN — Supplemental Application (Hospira, Inc.)

View source ↗

Summary

FDA approved a supplemental application for Bleomycin submitted by Hospira, Inc., updating the product's indications or labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hodgkin Lymphoma
• Testicular Cancer

Drugs mentioned

• Bleomycin (bleomycin)

Snippet

SUPPL AP for BLEOMYCIN (BLEOMYCIN)